DECLARATION OF PERSONAL INTERESTS 2018

Similar documents
ECHA DECLARATION OF INTERESTS1

ECHA DECLARATION OF INTEREST

ECHA DECLARATION OF INTEREST

Columbia University MORNINGSIDE ANNUAL CONFLICT OF INTEREST DISCLOSURE STATEMENT

iecha ECHA DECLARATION OF INTEREST

CIECHA ECHA DECLARATION OF INTERESTS1

:CiECHA ECHA DECLARATION OF INTERESTS1. There is a conflict of interest where the impartiality and objectivity of a decision, opinion

(ECHA EUROPEAN CHEMICALS AGENCY

CECHA EUROPEANCHEMICALSAGENCY Annex 3

ECHA DECLARATION OF INTEREST

Annex 1 Declaration of Interests Form

ICECHA EUROPEANCHEMCAL5AGENCY Annex 2

ECHA DECLARATION OF INTEREST

ECHA DECLARATION OF INTEREST

ECHA DECLARATION OF INTEREST

ECHA DECLARATION OF INTEREST

Annex 1 Declaration of Interests Form

Weill Cornell Medical College Study Specific Form FOR EXTERNAL NON-WCMC USE ONLY. Study Specific Report Form

fecha EUROPEAN CHEMICALSAGENCY

REGENERON PHARMACEUTICALS, INC. FINANCIAL CONFLICTS OF INTEREST POLICY FOR PHS-FUNDED RESEARCH

research must complete, even if they have used the coi.asco.org system)

5ECHA EUROPEAN CHEMICALS AGENCy

ACER. Annex 1 - Name: Position I Involvement in the Board or Agency 1:

Annex 1 Declaration of Interests Form

Financial Disclosure Form for Investigators in PHS Research

ECHA DECLARATION OF INTEREST

Journal of Clinical Oncology Author Submission preparation worksheet. Author Disclosure Declaration

AASM Conflict of Interest (COI) Policy September 2016

Central Office of Research Administration

RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC. (RFMH) FINANCIAL CONFLICT OF INTEREST POLICY

Financial Conflict of Interest Policy and Procedural Manual

Creation Date: 7/1/01 Title: Conflict of Interest Revision History:

Office of Research Administration

Johnson & Johnson Financial Conflicts of Interest Policy

UNIVERSITY OF WISCONSIN-STEVENS POINT OFFICE OF RESEARCH AND SPONSORED PROGRAMS

ECHA DECLARATION OF INTEREST

II. POLICY STATEMENT RELATING TO CONFLICTS OF INTEREST

SILENT SPRING INSTITUTE POLICY AND PROCEDURES ON FINANCIAL CONFLICTS OF INTEREST IN PUBLIC HEALTH SERVICE FUNDED RESEARCH

NYU LANGONE POLICY ON CONFLICTS OF INTEREST IN BUSINESS AFFAIRS. Issue Date: April 1, 2009 Reissue Date: June 29, Contents: I.

Dakota State University Policy Manual

USI Affinity Vision Summary

Conflict of Interest Policy for Research Investigators

Guidelines for Conflict of Interest Issues Related to Clinical Studies in Thoracic Surgery. Attached Documents

Standard Operating Procedures for Disclosure and Management of Financial Conflicts of Interest

UNI Office of Research and Sponsored Programs Policy on Conflicts of Interest Involving Research Funded by the Public Health Service

Vision Insurance Plan 3

Specialist Adviser questionnaire

DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST

MANUAL OF UNIVERSITY POLICIES PROCEDURES AND GUIDELINES. Applies to: faculty staff students student employees visitors contractors

(** Note: This Policy shall replace the current Section IV. Chapter 2 Policy in its entirety**). Section IV. Research and Sponsored Projects

CORPORATE COMPLIANCE: CONFLICT OF INTEREST

Paul Lorenz, MBA Chief Executive Officer, SCVMC. Continuing Medical Education (CME) Standards for Commercial Support

To: Vice Chancellors, Deans, Administrative Staff, Department Heads, and Students.

USI Affinity Vision Plan Summary

1. Disclosure of Significant Financial Interest means an Investigator s disclosure of significant financial interests to Monmouth University.

The Rockefeller University Policy on Financial Conflict of Interest in Research

CONFLICT OF INTEREST POLICY

Objectivity in Research and Investigator Financial Disclosure

John Kearny, Janice Nicholson, Patricia Notarangelo, Rebbie Pamintuan, Nadia Taylor. Additional Editors: Gwen Burrows Additional Readers:

ACUCELA INC. SIGNIFICANT FINANCIAL INTEREST DISCLOSURE FORM

Kaiser Permanente policy on conflicts of interest in research

CONFLICT OF INTEREST: ACCP PUBLICATIONS POLICY AND PROCEDURE

SAMPLE ANNUAL FORM 990 QUESTIONNAIRE (RELATIONSHIPS/TRANSACTIONS/INDEPENDENCE)

Dr. Joseph J. Timmes, Jr., M.D.

Division of Research Policy

INTERNATION CENTER FOR RESEARCH ON WOMEN (ICRW) PHS FUNDED RESEARCH FINANCIAL CONFLICT OF INTEREST (FCOI) POLICY

Administrative Procedure, AP Procedures for Disclosing and Addressing Conflicts of Interest and Commitment. Page 1 of 14

FINANCIAL CONFLICT OF INTEREST POLICY

ISO INTERNATIONAL STANDARD. Medical devices Application of risk management to medical devices

TEMPLE UNIVERSITY BOARD OF TRUSTEES POLICIES AND PROCEDURES MANUAL

PHS Financial Disclosure Form

Biomedical Research Institute of New Mexico. Financial Conflict of Interest Objectivity in Research

Akron General Health System Financial Conflict of Interest Reference Sheet

Florida Agricultural and Mechanical University Board of Trustees Policy

Investigators, which includes any individual responsible for the design, conduct, or reporting of the research.

RICHMOND EYE ASSOCIATES, P.C.

CONFLICTS OF INTEREST IN RESEARCH

POLICY ON DISCLOSURE OF SIGNIFICANT FINANCIAL INTEREST

PROBATE/TRUST ADMINISTRATION QUESTIONNAIRE

THE EXECUTIVE BENEFITS PLAN

CAROLINAS HEALTHCARE SYSTEM OFFICE OF CLINICAL AND TRANSLATIONAL RESEARCH STANDARD OPERATING PROCEDURE

Financial Conflict of Interest Policy

The Rockefeller University Policy on Financial Conflict of Interest and Conflict of Commitment in Research. Financial Conflict of Interest

First-Half Financial Report 2017 /18 Carl Zeiss Meditec Group

Policy Number: Location: Origination Date: Date of Last Review: Baylor Research Institute 8/24/2012 7/11/2012

Executive Branch Personnel Public Financial Disclosure Report (OGE Form 278e)

American Thoracic Society International Conference SUMMARY AND DEFINITIONS OF ATS POLICIES ON CONFLICT OF INTEREST AND TOBACCO INDUSTRY RELATIONSHIPS

Moffitt Cancer Center

Vision Program. Effective January 1, Introduction How the Program Works... 2

Come take a closer look. Set your sights on vision insurance that s right for you.

ISO INTERNATIONAL STANDARD. Medical devices Application of risk management to medical devices

This issue Your Ambulance Coverage...1 Reminder: Once Pension Benefits

MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR ASCENSION

Financial Conflict of Interest. V001 November 14, 2014

Group Vision Care Policy

Palliative Care Quality Network Membership Agreement

Information note. Edition Complementary health insurance WHO

MSSNG A Program of Autism Speaks Inc. 85 Devonshire St Boston, MA 02109, USA (617) MSSNG DATABASE ACCESS AGREEMENT (DAA) (VERSION 1.

University of New England Investigator Significant Financial Interest Disclosure Policy for Sponsored Projects Originally Adopted March 2005

Policy on Conflicts of Interest in Clinical Care

Transcription:

LAST NAME, First name: SLINEY, David CURRENT OR APPLIED POSITION WITHIN ICNIRP: ACTIVITIES AND ASSETS Always mention the title of the activity, function, asset listed, and the name of company, organization, or institution involved. EMPLOYMENT (main employer, function, title) US Army Medical Department (Army Environmental Hygiene Agency; US Army Center for Health Promotion and Preventive Medicine, Aberdeen Proving Ground, MD 21010, USA Johns Hopkins University, School of Public Health (Department of Environmental Science and Engineering, Baltimore, MD Period 2014-2017 and 2018 Please, also report any current application or negotiation for future work Period: 1965-2007; Now retired on pension. Period: 1979 2018 (associate paid/lecture) UNPAID CONSULTANCY, ADVISORY POSITIONS AND SERVICES Unpaid consultancy including service as a scientific or other advisor. Unpaid advisory office or services for a commercial entity or any organizations and/or as part of a regulatory legislative or judicial process with an interest in NIR (i.e. membership in scientific councils, associations, etc.): Name and description of the activity 1. American Academy of Ophthalmology, Annual Advisor on optical/rf safety for meetings and exhibits of laser technology 2. American Society for Laser Medicine and Surgery, Annual Advisor on optical/rf safety for meetings and exhibits of laser technology 3. CIE (International Commission on Illumination), Associate Director of Division 6, Photochemistry and Photobiology 4. American Conference of Governmental Industrial Hygienists (ACGIH), Physical Agents TLV Committee (non-profit organization) recommends occupational limits for physical factors (including NIR) Personal advantages (hospitality, prestige, etc. - specify and quantify ) 1. Some hotel/travel reimbursed in both cases and free meeting registration 2. Some hotel/travel reimbursed in both cases and free meeting registration 3. Prestige? Scientific interest. No 4. Prestige? Scientific interest. No Period: 2017 DECLARATION OF PERSONAL INTERESTS POLICY AND FORM 2

5. American National Standards Institute (ANSI) voluntary standards committees Participates in: ANSI Z80 ophthalmic lenses and sunglasses; and ANSI Z136, Safe Use of Lasers 6. Illuminating Engineering Society of North America serves as chair of the photobiology committee. 7. International Standards Organization (ISO) participates in technical committees: ISO TC172 ophthalmic optics and instruments; and ISO TC94 Personal protective equipment, including sunglasses. 8. International Electrotechnical Commission (IEC) participates in technical committees TC61 Household Equipment, MT-16 ultraviolet and infrared home appliances; and WG39 (LED safety); and IEC TC76 Lasers I serve as Convener of WG-1 (Radiation Safety) and this TC employs ICNIRP guidelines as a basis for some emission limits, but all decisions are based on science. 5. Prestige? Scientific interest. No 6. Prestige? Scientific interest. No 7. Scientific interest. No 8. Scientific interest. No PAID CONSULTANCY, ADVISORY POSITIONS AND SERVICES Paid consultancy including service as a scientific or other advisor. Paid advisory office or services for a commercial entity or any organizations and/or as part of a regulatory legislative or judicial process with an interest in NIR (i.e. membership in scientific councils, associations, etc.): Name and description of the activity: Optical Safety of Medical Instruments; improving optical design for patient safety. Nothing connected with regulatory legislative or judicial processes. Name and status of the contractor (none have a significant interest in NIR, but are listed): NOTE: All contracts were for 1-10 days, with most about 2-day efforts. 1. Ecole polytechnique Fédérale de Lausanne (EPFL); Laboratory of Applied Photonics Devices (University), CH review of ophthalmic instrument design and safety 2. University of Illinois, Dept of Biomedical Engineering (University) review instrument design 3. Karl Zeiss Jena, Germany (optical instrument company) re. laser surgical instruments. 4. Gecko Biomedical, Paris, France (optical instrument company) re. surgical instruments. All: Income amount and percentage of yearly laboratory/working group/personal income (specify): 1. Less than 1% 2. Less than 1% 3. Less than 2% 4. Less than 1% ~10% for all consultancies. 1. 2017 2. 2016 3. 2016-2017 4. 2015, 2017 5. 2017 2017 DECLARATION OF PERSONAL INTERESTS POLICY AND FORM 3

5. OD/OS, Tetlow, Germany (Ophthalmic laser company) Review and comment on safety assessment of laser retinal photocoagulators 6. Technolas, Munich, Germany. Review and comment on safety assessment of laser cataract surgical system. 7. Alcon Surgical, Milpitas, CA (USA), Review and comment on safety assessment of surgical light sources and ophthalmic laser systems. 8. Seeing Machines (Australia) Driver alerting infrared systems review occupational safety 5. Less than 1% 6. Less than 1% 7. Less than 1% 8. Less than 0.5% 6, 2015, 2017 7. 2016, 2017 201 RESEARCH SUPPORT RECEIVED FROM COMMERCIAL ENTITIES Grants, collaborations, sponsorships, other funding and in kind support valued at more than EUR 1000 overall (include equipment, facilities, staff, paid travel to meetings, etc.) Name and description of the activity: N/A Name and status of the contractor: N/A Which unit receives and manages the research funding from the above activity? University/Unit/Laboratory/Personal Research Fund/Other: N/A It is assumed that you are free of publishing whatever results your research shows without the influence from the entity funding your research. Is this explicitly stated within the contract? Income amount and percentage of yearly laboratory/unit/personal income (specify) : N/A Period: 0 Please describe how your independence is safeguarded: N/A If, yes. Please specify the wording used in the contract: Yes X No 2017 DECLARATION OF PERSONAL INTERESTS POLICY AND FORM 4

INVESTMENTS AND COMMERCIAL INTERESTS Investments (income valued at more than EUR 1 000) in a commercial entity, in a trust or holding company with an interest related to NIR. List, for example, any commercial business interests (e.g., proprietorships, partnerships, joint ventures) and stocks, bonds, stock options, other securities (e.g., short sales) - excluding broadly diversified mutual funds, pension funds or similar investments. Investment/Share: Income: INTELLECTUAL PROPERTY Such as patents, trademarks, or copyrights (also include pending applications) and proprietary know-how in a substance, technology or process. Property: None applicable Income: 0 ADDITIONAL INFORMATION When relevant, please provide details about the subject, the parties involved, the time-frame and any other relevant details. To your knowledge, would the outcome of your activities within ICNIRP benefit or adversely affect interests of others with whom you have substantial common personal, financial or professional interests (such as your spouse or partner, adult children or siblings)? No Is there any other aspect of your background or present circumstances not addressed above that might be perceived as affecting your objectivity or independence? No I hereby declare that the disclosed information is true and complete to the best of my knowledge. Should there be any change to the above information, I will promptly notify the ICNIRP Secretariat and complete a new declaration of interests which takes the changes into account. 2017 DECLARATION OF PERSONAL INTERESTS POLICY AND FORM 5

Date: 4 October 2017 Name: David H. Sliney Signature: David H. Sliney 2017 DECLARATION OF PERSONAL INTERESTS POLICY AND FORM 6